Federal Prisons Naloxone Access Act of 2025
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
This bill amends federal law to require the Bureau of Prisons to maintain opioid antagonist kits (such as naloxone) at all federal correctional facilities in multiple accessible locations, including medical units, staff areas, and common spaces. The bill mandates annual training for staff and incarcerated persons on administering opioid antagonists and recognizing overdose signs, requires documentation of each administration, and protects incarcerated persons from liability for administering antagonists in good faith. The Bureau of Prisons must submit annual reports to Congress on compliance, including data on overdoses, trainings, and expired kits.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.